The MG Composite: A valid and reliable outcome measure for myasthenia gravis

Neurology

Volumn 74, Issue 18, 2010, Pages 1434-1440

  Burns, Ted M ^a   Conaway, Mark ^a   Sanders, Donald B ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONCURRENT VALIDITY; CONSTRUCT VALIDITY; HUMAN; MAJOR CLINICAL STUDY; MYASTHENIA GRAVIS; MYASTHENIA GRAVIS COMPOSITE SCALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE INDEX; RATING SCALE; SENSITIVITY AND SPECIFICITY; TEST RETEST RELIABILITY;

EID: 77951810213     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181dc1b1e     Document Type: Article

References (24)

1. Barohn RJ, McIntire D, Herbelin L, Wolfe GI, Nations S, Bryan WW. Reliability testing of the quantitative myas-thenia gravis score. Ann NY Acad Sci 1998;841:769-772.
2. Barohn RJ. Standards of measurement in myasthenia gra-vis. Ann NY Acad Sci 2003;998:432-439.
3. Burns TM, Conaway MR, Cutter GR, Sanders DB. The construction of an efficient evaluative instrument for my-asthenia gravis: the MG Composite. Muscle Nerve 2008; 38:1553-1562.
4. Burns TM, Conaway M, Cutter G, Sanders DB, The Muscle Study Group. Less is more, or almost as much: the development of a fifteen-item quality-of-life instrument for patients with myasthenia gravis. Muscle Nerve 2008; 38:957-963.
5. Drachman DB, Adams RN, Josifek LF, Self SG. Functional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis. N Engl J Med 1982;307:769-775.
6. Farrugia ME, Robson MD, Clover L, et al. MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis. Brain 2006; 129:1481-1492.
7. Gajdos P, Sharshar T, Chevret S. Standards of measurements in myasthenia gravis. Ann NY Acad Sci 2003;998: 445-452.
8. Jaretzki A, Barohn RJ, Ernstoff RM, et al, for the Task Force of the Medical Scientific Advisory Board of the My-asthenia Gravis Foundation of America. Myasthenia gra-vis: recommendations for clinical research standards. Neurology 2000;55:16-23.
9. Mantegazza R, Antozzi C, Pelucchetti D, Sghirlanzoni A, Cornelio F. Azathioprine as a single drug or in combina tion with steroids in the treatment of myasthenia gravis. J Neurol 1988;235:449-453.
10. Mullins LL, Carpentier MY, Paul RH, Sanders DB, Muscle Study Group. A disease-specific measure of quality of life for myasthenia gravis. Muscle Nerve 2008;38:947-956.
11. Palace J, Newsom-Davis J, Lecky B, Myasthenia Gravis Study Group. A randomized double-blind trial of pred-nisolone alone or with azathioprine in myasthenia gravis. Neurology 1998;50:1778-1783.
12. Padua L, Evoli A, Aprile I, et al. Myasthenia gravis outcome measure: development and validation of a disease-specific self-administered questionnaire. Neurol Sci 2002;23:59-68.
13. Sanders DB, Tucker-Lipscomb B, Massey JM. A simple manual muscle test for myasthenia gravis: validation and comparison with the QMG score. Ann NY Acad Sci 2003; 998:440-444.
14. Sharshar T, Chevret S, Mazighi M, et al. Validity and reliability of two muscle strength scores commonly used as endpoints in assessing treatment of myasthenia gravis. J Neurol 2000;247:286-290.
15. Wolfe GI, Herbelin L, Nations SP, Foster B, Bryan WW, Barohn RJ. Myasthenia gravis activities of daily living profile. Neurology 1999;52:1487-1489.
16. Muscle Study Group. A trial of mycophenolate mofetil with prednisone as initial immunotherapy in myasthenia gravis. Neurology 2008;71:394-399.
17. Sanders DB, Hart IK, Mantegazza R, et al. An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis. Neurology 2008;71:400-406.
18. Fleis J. The Design and Analysis of Clinical Experiments. New York: John Wiley and Sons; 1986.
19. Rosner B. Fundamentals of Biostatistics, 6th edition. Bel-mont, CA: Thomson Brooks/Cole; 2006.
20. Swets JA. Measuring the accuracy of diagnostic systems. Science 1988;240:1285-1293.
21. Mantegazza R, Beghi E, Pareyson D, et al. A multicentre follow-up study of 1152 patients with myasthenia gravis in Italy. J Neurol 1990;237:339-344.
22. Grob D, Brunner N, Namba T, Pagala M. Lifetime course of myasthenia gravis. Muscle Nerve 2008;37: 141-149.
23. Oosterhuis HJGH. Studies in myasthenia gravis: part 1: a clinical study of 180 patients. J Neurol Sci 1964;1:512-546.
24. Keesey JC. Clinical evaluation and management of myas-thenia gravis. Muscle Nerve 2004;29:484-505.